Friday, March 29, 2024

Pfizer

Pfizer says COVID-19 pill cut hospital, death risk by 90 per cent

By PTI WASHINGTON: Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in...

With domestic manufacturing picking up pace, India unlikely to buy Pfizer, Moderna vaccines for now: Sources

By PTI NEW DELHI: India is unlikely to buy Pfizer and Moderna COVID-19 vaccines for now as the domestic manufacturing of anti-coronavirus jabs has...

Pfizer, Moderna vaccines wouldn’t have got nod had they done phase three trials in second wave: Krishna Ella

Hyderabad-based Bharat Biotech, the manufacturer of COVID-19 Covaxin, said the efficacy of its vaccine would have been 85 per cent against the original strain of the virus.

Pfizer-BioNtech vaccine set to be first fully approved coronavirus jab 

Express News Service NEW DELHI:  The Covid-19 vaccine developed by Pfizer-BioNtech is set to become the first jab against the disease globally to move from emergency-use...

Pfizer, AstraZeneca vaccine antibody levels may decline after 2-3 months: Lancet study

By PTI LONDON: Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more...

Centre dragging feet on granting necessary approvals to Pfizer, Moderna: SAD chief Sukhbir Singh Badal

By PTI AMRITSAR: Shiromani Akali Dal (SAD) chief Sukhbir Singh Badal on Saturday accused the Centre of dragging its feet on granting US pharma...

Pursuing Pfizer, J&J and Moderna since mid-2020 for earliest possible vaccine imports: Government

Express News Service NEW DELHI: Amid continuing criticism of its vaccination policy, the Centre on Thursday tasked its top COVID-19 advisor VK Paul to bust "myths" with...

Centre waives ‘bridging trials’ to allow foreign vaccines for emergency use

Express News Service NEW DELHI: The Centre has now decided to exempt foreign Covid vaccine makers from bridging trials in India completely, after announcing last month...

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to government

By PTI NEW DELHI: Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has shown...

Moderna’s single-dose COVID-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021

By PTI NEW DELHI: Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among...

Latest News

Now weapons will not be raised… 3 Naxalites including rewarded Naxalite surrendered, 685 Maoists have returned home

Dantewada. Influenced by the Lon Varatu (Come Back Home) campaign, 3 Maoists including 1 rewarder have laid down...